Raymond James Financial
FLNA

Raymond James Financial’s Filana Therapeutics FLNA Stock Holding History

Raymond James Financial’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5K Sell
15,570
-1,534
-9% -$2.19K ﹤0.01% 5331
2026
Q1 		$28.9K Sell
17,104
-13,360
-44% -$27.5K ﹤0.01% 5179
2025
Q4 		$60.3K Buy
30,464
+13,496
+80% +$43.2K ﹤0.01% 4990
2025
Q3 		$49.4K Sell
16,968
-837
-5% -$1.93K ﹤0.01% 4825
2025
Q2 		$32.2K Sell
17,805
-37,592
-68% -$66.9K ﹤0.01% 5376
2025
Q1 		$83.1K Sell
55,397
-6,853
-11% -$17.3K ﹤0.01% 4576
2024
Q4 		$147K Buy
+62,250
New +$1.09M ﹤0.01% 4471

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Raymond James Financial's FLNA Position: Q2 2026 in Review

Raymond James Financial reduced its Filana Therapeutics (FLNA) stake by 9% in Q2 2026, selling an estimated $2.19K and leaving 15,570 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5331.

Raymond James Financial first reported a position in FLNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $147K in Q4 2024. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Raymond James Financial held 15,570 shares of Filana Therapeutics worth $18.5K as of Q2 2026.
  • Raymond James Financial sold 1,534 Filana Therapeutics shares in Q2 2026, an estimated $2.19K.
  • Filana Therapeutics made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5331 holding.
  • Raymond James Financial first reported a position in Filana Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Filana Therapeutics position peaked at $147K in Q4 2024.
  • 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.